Compare SPOK & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPOK | QSI |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.7M | 194.8M |
| IPO Year | 2004 | N/A |
| Metric | SPOK | QSI |
|---|---|---|
| Price | $10.85 | $0.97 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $14.00 | $1.00 |
| AVG Volume (30 Days) | 138.8K | ★ 6.3M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 11.31% | N/A |
| EPS Growth | ★ 2.74 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $139,708,000.00 | N/A |
| Revenue This Year | $1.70 | N/A |
| Revenue Next Year | N/A | $618.07 |
| P/E Ratio | $119.89 | ★ N/A |
| Revenue Growth | ★ 1.49 | N/A |
| 52 Week Low | $9.95 | $0.69 |
| 52 Week High | $19.31 | $3.10 |
| Indicator | SPOK | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 50.28 | 44.46 |
| Support Level | $10.87 | $0.87 |
| Resistance Level | $11.55 | $1.08 |
| Average True Range (ATR) | 0.26 | 0.11 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 65.76 | 12.18 |
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.